Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,015.00    -10.00 (-0.17%)
Bid:
6,005.00
Ask:
6,010.00
Spread: 5.00 (0.083%)
Market Cap: £5.14b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Form 38.5a-DCC PLC

12 May 2026 11:48

RNS Number : 0097E
GoldmanSachs International
12 May 2026
 

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

DCC PLC

Class of relevant security to which the dealings being disclosed relate (Note1)

EUR 0.25 ordinary shares

Date of dealing

11 May 2026

 

2. DEALINGS (Note 2)

(a) Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid (Note 3)

125,236

58.1000 GBP

57.4467 GBP

 

Total number of relevant securities disposed

Highest price received (Note 3)

Lowest price received (Note 3)

142,784

58.0500 GBP

57.2750 GBP

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 4)

Number of relevant securities  (Note 5)

Price per unit  (Note 3)

CFD

Reducing a short position

576

57.3147 GBP

CFD

Reducing a long position

1,433

57.4467 GBP

CFD

Increasing a short position

31

57.4645 GBP

CFD

Increasing a short position

120

57.4683 GBP

CFD

Increasing a short position

45

57.4992 GBP

CFD

Reducing a long position

98

57.5005 GBP

CFD

Reducing a long position

2,836

57.5170 GBP

CFD

Increasing a short position

988

57.5190 GBP

CFD

Reducing a long position

1,346

57.5290 GBP

CFD

Reducing a long position

2,333

57.5325 GBP

CFD

Increasing a long position

1,808

57.5368 GBP

CFD

Increasing a long position

4,862

57.5368 GBP

CFD

Closing a long position

657

57.5452 GBP

CFD

Opening a short position

380

57.5452 GBP

CFD

Increasing a short position

82

57.5500 GBP

CFD

Reducing a long position

1,335

57.5500 GBP

CFD

Reducing a short position

768

57.5539 GBP

CFD

Reducing a short position

152

57.5546 GBP

CFD

Reducing a short position

4,560

57.5546 GBP

CFD

Reducing a short position

88

57.5546 GBP

CFD

Reducing a short position

62

57.5546 GBP

CFD

Reducing a short position

125

57.5546 GBP

CFD

Reducing a short position

182

57.5546 GBP

CFD

Reducing a short position

42

57.5546 GBP

CFD

Reducing a long position

442

57.5649 GBP

CFD

Increasing a long position

6,233

57.5755 GBP

CFD

Reducing a short position

25

57.5816 GBP

CFD

Reducing a long position

435

57.5865 GBP

CFD

Increasing a short position

333

57.6069 GBP

CFD

Increasing a short position

48

57.6069 GBP

CFD

Reducing a long position

2

57.6150 GBP

CFD

Increasing a short position

140

57.6500 GBP

CFD

Reducing a short position

332

57.6711 GBP

CFD

Closing a short position

3

57.6711 GBP

CFD

Closing a short position

100

57.6711 GBP

CFD

Increasing a long position

5,357

57.7002 GBP

CFD

Increasing a long position

804

57.7210 GBP

CFD

Increasing a long position

114

57.7481 GBP

CFD

Reducing a short position

204

57.8156 GBP

CFD

Reducing a short position

24

57.8750 GBP

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates  (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 3)

 

(ii) Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 3)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 

NONE

 

Date of disclosure

12 May 2026

Contact name

Papa Lette and Andrzej Szyszka

Telephone number

+33(1) 4212 1459 / +48(22) 317 4817

Name of offeree/offeror with which connected

ENERGY CAPITAL PARTNERS, LLC AND KOHLBERG KRAVIS ROBERTS & CO. L. P. (TOGETHER THE "CONSORTIUM")

Nature of connection (Note 6)

Advisor to Offeree

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPDZGMKGZNGVZM
Date   Source Headline
14th Jul 20202:28 pmRNSHolding in Company TR-1
8th Jul 202011:38 amRNSHolding in Company TR-1
24th Jun 20209:39 amRNSHolding in Company TR-1
18th Jun 202012:25 pmRNS2020 Annual Report, Notice of AGM and Proxy Form
3rd Jun 202010:10 amRNSHolding in Company TR-1
29th May 202011:27 amRNSTotal Voting Rights
28th May 20206:21 pmRNSDirector/PDMR Shareholding
28th May 20201:02 pmRNSHolding in Company TR-1
19th May 20205:04 pmRNSBoard Changes
19th May 20207:00 amRNSResults for the year ended 31 March 2020
14th May 20203:30 pmRNSHolding in Company TR-1
27th Apr 20206:02 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20204:24 pmRNSDirector Declaration
9th Apr 20204:21 pmRNSHolding in Company TR-1
3rd Apr 20204:01 pmRNSHolding in Company TR-1
25th Mar 20203:22 pmRNSHolding in Company TR-1
25th Mar 20207:00 amRNSDCC Healthcare announces acquisition of Amerilab
19th Mar 20204:10 pmRNSHolding in Company TR-1
19th Mar 20209:46 amRNSHolding in Company TR-1
18th Mar 202012:14 pmRNSHolding in Company TR-1
6th Mar 20204:08 pmRNSHolding in Company TR-1
28th Feb 202010:54 amRNSTotal Voting Rights
24th Feb 20208:38 amRNSBoard Change
24th Feb 20208:34 amRNSChief Financial Officer Succession
12th Feb 20209:10 amRNSHolding in Company TR-1
4th Feb 20207:00 amRNSInterim Management Statement
17th Jan 20209:23 amRNSHolding in Company TR-1
3rd Jan 202010:03 amRNSHolding in Company - TR1
23rd Dec 201912:44 pmRNSHolding in Company TR-1
5th Dec 20195:44 pmRNSHolding in Company - TR1
29th Nov 20191:39 pmRNSTotal Voting Rights
27th Nov 20199:18 amRNSDirector Declaration
18th Nov 20196:14 pmRNSDirector/PDMR Shareholding
12th Nov 20197:00 amRNSResults for the six months ended 30 September 2019
12th Nov 20197:00 amRNSDCC Healthcare acquires Ion Laboratories
7th Nov 201911:30 amRNSHolding in Company TR-1
23rd Oct 20192:25 pmRNSHolding in Company TR-1
21st Oct 20195:01 pmRNSHolding in Company TR-1
18th Oct 20194:46 pmRNSHolding in Company TR-1
17th Oct 20199:43 amRNSHolding in Company TR-1
25th Sep 20195:39 pmRNSHolding in Company TR-1
4th Sep 20199:57 amRNSHolding in Company TR-1
9th Aug 201910:42 amRNSHolding in Company TR-1
7th Aug 20199:23 amRNSHolding in Company TR-1
31st Jul 20192:58 pmRNSTotal Voting Rights
16th Jul 20196:14 pmRNSDirector/PDMR Shareholding
12th Jul 20193:06 pmRNSResult of AGM
12th Jul 20197:00 amRNSInterim Management Statement
5th Jul 20199:06 amRNSHolding in Company TR-1
19th Jun 20199:22 amRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.